High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.

Source:http://linkedlifedata.com/resource/pubmed/id/7909685

Download in:

View as

General Info

PMID
7909685